Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person SQSTM1(2-251)-ALK(1058-1620) fusion [cytosol]

Class:Id	EntityWithAccessionedSequence:9711954
_displayName	SQSTM1(2-251)-ALK(1058-1620) fusion [cytosol]
_timestamp	2021-01-13 23:43:44
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9711957] Rothfels, Karen, 2021-01-13
crossReference	[DatabaseIdentifier:9711750] COSMIC:COSF1051
disease	[Disease:9632617] diffuse large B-cell lymphoma [Disease:8853117] lung adenocarcinoma
endCoordinate	251
hasModifiedResidue	[FragmentInsertionModification:9711919] Insertion of residues 1058 to 1620 at 252 from UniProt:Q9UM73 ALK
literatureReference	[LiteratureReference:9711814] Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma [LiteratureReference:9711812] Novel ALK fusion partners in lung cancer
name	SQSTM1(2-251)-ALK(1058-1620) fusion Sequestosome-1 SQSTM_HUMAN
referenceEntity	[ReferenceGeneProduct:193910] UniProt:Q13501 SQSTM1 [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9711996] R-HSA-9711954.1
startCoordinate	2
(hasCandidate)	[CandidateSet:9700080] ALK fusion proteins [cytosol] [Homo sapiens]
(hasComponent)	[Complex:9712008] SQSTM1(2-251)-ALK(1058-1620) fusion dimer [cytosol] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by SQSTM1(2-251)-ALK(1058-1620) fusion [cytosol] (9711954)